Our long-term objective is to elucidate the molecular mechanisms of transcriptional regulation of human gene expression in response to Amyloid Precursor Protein (APP) signaling. APP is a transmembrane protein that is the precursor of the beta-amyloid peptide (Abeta), the major component of amyloid plaques that characterize Alzheimer's disease. This peptide is generated from APP through proteolysis by the beta- and gamma-secretases. Following proteolysis, the released 47-residue cytoplasmic domain of APP (APP-C) interacts with the proteins Fe65 and TIP60, forming a nuclear complex that regulates gene expression. However, despite the central importance of the APP-C in human physiology and Alzheimer's disease pathogenesis, the sequence-specific DNA-binding transcription factors that recruit the TIP60/Fe65/APP-C complex onto the promoters of human genes and the molecular mechanisms underlying the transcriptional regulation by this complex remain elusive. TIP60 has histone acetyltransferase (HAT) activity with unique substrate specificity and interacts with class I nuclear receptors, supporting the hypothesis that these transcription factors may mediate APP-C signaling in the nucleus. This proposal will test this hypothesis and will focus on a mechanistic analysis of the APP-C signaling in gene regulation.
The Specific Aims are: 1) To dissect the molecular mechanisms of gene regulation by the TIP60/Fe65/APP-C complex through its association with the androgen and estrogen receptors, using protein-protein interaction assays, in combination with site-directed mutagenesis and transient transfection experiments. 2) To elucidate the structural basis of the TIP60 HAT substrate specificity and the structural determinants of the TIP60 interaction with the androgen and estrogen receptors. 3) To determine the three-dimensional conformational changes induced on the TIP60/Fe65 complex by the APP-C binding, using X-ray crystallography. These studies will provide high-resolution three-dimensional structures of the TIP60, Fe65, and APP-C proteins, and will provide mechanistic insights into the regulation of human gene expression in response to APP signaling. This information could be used for the development of novel strategies in the treatment of Alzheimer's disease.
| Birrane, Gabriel; Soni, Aditi; Ladias, John A A (2009) Structural basis for DNA recognition by the human PAX3 homeodomain. Biochemistry 48:1148-55 |
| Durney, Michael A; Birrane, Gabriel; Anklin, Clemens et al. (2009) Solution structure of the human Tax-interacting protein-1. J Biomol NMR 45:329-34 |
| Tischkowitz, Marc; Hamel, Nancy; Carvalho, Marcelo A et al. (2008) Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach. Eur J Hum Genet 16:820-32 |
| Meiyappan, Muthuraman; Birrane, Gabriel; Ladias, John A A (2007) Structural basis for polyproline recognition by the FE65 WW domain. J Mol Biol 372:970-80 |
| Baek, Kyuwon; Brown, Raymond S; Birrane, Gabriel et al. (2007) Crystal structure of human cyclin K, a positive regulator of cyclin-dependent kinase 9. J Mol Biol 366:563-73 |
| Birrane, Gabriel; Varma, Ashok K; Soni, Aditi et al. (2007) Crystal structure of the BARD1 BRCT domains. Biochemistry 46:7706-12 |
| Varma, Ashok K; Brown, Raymond S; Birrane, Gabriel et al. (2005) Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex. Biochemistry 44:10941-6 |
